... consistent benefit includeindomethacin, somatostatin analogs, caffeine, ergotalkaloids, and nocturnal desmopressin. L-threo-3, 4-dihydroxyphenylserine is used in the rare but dis-tinctive entity, ... Brain, 81 , 157.Azulay, J.P., Blin, O., Pouget, J. et al. 1994. Intravenousimmunoglobulin treatment in patients with motor-neuron syndromes associated with anti-Gm1 anti-bodies – A double-blind, ... andneuronopathy. Seminars Neurol, 19 98; 18, 7– 18. Barohn, R.J., Kissel, J.T., Warmolts, J.R. and Mendell, J.R.1 989 . Chronic in ammatory demyelinating poly-radiculoneuropathy – Clinical characteristics,...